NCT00984880View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD3043

Intravenous solution given as bolus dose (part A) and as bolus dose followed by infusion (part B)

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY